Aprea Therapeutics, Inc. APRE

Full chart Compare
Set alert

Price alert · APRE

All alert types
0.52 USD +0.02 (+4.89%)

At closeNov 3, 2026, 4:02 PM EST

0.52 0.00 0.00%

After hours · Nov 3, 4:02 PM ET

0.48 Day range 0.5166
0.41 52-week range 1.49
YTD
-39.62%
1 year
-63.21%

Analyst view

Consensus: buy

Buy
Price target (mean) 15.67 +2942.1% upside
Target (low)
11.00
Target (mean)
15.67
Target (high)
20.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3
  • 1 month ago 3
  • 2 months ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

APRE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.57-0.57 – -0.57-0.92+38.0%0-100.0%1
Next quarter0.000.00 – 0.000.000.0%0-100.0%0
Current year-2.41-2.41 – -2.41-3.95+39.0%1.11M+90.0%1
Next year-0.97-0.97 – -0.97-2.41+59.8%633.33K-42.8%1

Upgrades and downgrades

The latest rating changes

APRE analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 13, 2024WedbushReiteratedOutperformOutperform
Aug 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 27, 2024WedbushMaintainedOutperformOutperform
Mar 26, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 1, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 13, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 10, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2023HC Wainwright & Co.ReiteratedBuyBuy
Mar 10, 2023Maxim GroupInitiated—Buy